To investigate the effects of an inhomogeneous (0.3-1 µT), alternating magnetic field on tumor development and melatonin levels in DMBA treated rats.
A total of 72 animals were used in this study (divided into two groups/36 animals each). One group was MF-exposed, the other one served as sham-exposed control. Each animal obtained an initial oral administration of 5 mg DMBA prior the onset of exposure/sham-exposure. DMBA administration was repeated weekly up to a total dose of 20 mg.
| Exposure | Parameters |
|---|---|
|
Exposure 1:
50 Hz
Exposure duration:
24 h/day, 7 days/week, for 91 days
|
|
Rats were assigned to two groups, a sham exposue group (n= 36) and a magnetic field exposure group (n= 36).
| Frequency | 50 Hz |
|---|---|
| Type | |
| Waveform | |
| Exposure duration | 24 h/day, 7 days/week, for 91 days |
| Exposure source |
|
|---|---|
| Setup | Rats recieved administration of 5 mg DMBA (dimethylbenz(a)anthracene) per week (for 4 weeks up to a total of 20 mg) and were housed in Plexiglass cages surrounded by the coils. |
| Sham exposure | A sham exposure was conducted. |
| Measurand | Value | Type | Method | Mass | Remarks |
|---|---|---|---|---|---|
| magnetic flux density | 300 nT | minimum | measured | - | - |
| magnetic flux density | 1 µT | maximum | measured | - | - |
No significant differences between groups were found in general behavior, body weight, or weight of spleen and liver. Also histopathological examination of tumors did not reveal any significant differences between the MF-exposed and the sham-exposed group. However, nocturnal melatonin serum levels were significantly reduced in the MF-exposed group.
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
